Local Institution

Corona, California 92880

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Cancer, Hypertension, Leukemia, Lymphocytic, Acute, L2, Leukemia, Myeloid, Chronic, Lymphoma, Multiple Myeloma, Non-Small-Cell Lung Carcinoma, Rheumatoid Arthritis

Studies at this site

• Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) — Running, not enrolling
• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate — Completed
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension — Completed
• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed